Response to Commentary on “Prevalence of Local IgE Elevation and Its Effect on Intranasal Capsaicin Therapy in the Nonallergic Rhinitis Population”
Martin J. Citardi: Consultant for 3D Matrix, Acclarent, Latica, MicroGenDx, Medtronic. Amber U. Luong: Consultant for Lyra Therapeutics, Maxwell Bioscience, Stryker ENT, Medtronic, NeurENT, SoundHealth, Sanofi; Advisory Board member for AstraZeneca, GlaxoSmithKline and Sanofi; Grant support from Insmed and Sanofi. William C. Yao: Consultant for Aerin Medical, Optinose Inc. The other authors declare no conflicts of interest.
Authors
- GP Cruz
- Amber Luong (ORCID: https://orcid.org/0000-0001-6078-8010)
- William C. Yao (ORCID: https://orcid.org/0000-0002-9845-2165)
- Faramarz Ashoori
- Martin J. Citardi (ORCID: https://orcid.org/0000-0002-1155-9235)
- David Z. Allen (ORCID: https://orcid.org/0000-0002-6727-4378)
- Kunal Shetty (ORCID: https://orcid.org/0000-0001-8091-5953)
- Dylan G. Vance (ORCID: https://orcid.org/0000-0002-2124-8510)
- Salman Hasan
- Elaijah Islam
- Christopher Bankston
Institutions
- The University of Texas Health Science Center (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1002/alr.70054
- Primary Topic
- Sinusitis and nasal conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00